Page 1409 - Problem-Based Feline Medicine

DRUG INDEX
20 – THE CAT WITH ENLARGED LYMPH NODES 14011401

Continued

time of dilation

7 d 3–8 times daily
24 for 24–48 24–48 q 2 wk q 3–4 wk 8–12 8–12 8–12 8–12 12–24
24 24 at 24 12 12 12 12 12 8 1 24
submucosal infiltration subconjunctivally

topically PO PO, IM, SC PO PO IM, SC IM, SC PO PO intravesicularly IM IM IM, PO Apply topically PO PO, SC PO, IV PO, IM IV IM PO IV IM

1 mg of tumor

0.25–0.50 mg 0.11–0.22 mg/kg 2–4 mg 0.5–1.0 mg/kg 0.11–0.22 mg/kg 1–2 mg/cat 0.1–0.2 mg/kg Intralesional: 1.2–1.8 mg or every 1 cm diameter for 4 mg 1–2 mg/kg 10–15 mg/kg 30 mg/m 2 0.13–0.2 mg/kg 0.03 mg/kg 0.1–0.3 mg/kg 0.1% soln: 1–2 drops 4.4 μ/kg 15 mg/kg 15 mg/kg 1 mg/kg 4 mg/kg 6.6–11 mg/kg 25 mg 300 mg 2 mg/cat

Canine and feline acne, nasal hyperkeratosis Feline plamacytic pharyngitis, pododermatitis Feline polymyopathy Anti inflammatory Esophageal stricture Glucocorticoid effects Pannus, eosinophilic keratitism episcleritis Diuretic Chelating agent neoplasia Bladder Antipsychotic Antipsychotic modification Behavior Ocular herpesvirus infection Hypothyroidism Routine infections Meningitis Antihi

Tretinoin Triamcinolone Triamcinolone acetonide Triamcinolone Triamterene Trientine hydrochloride Triethylene thio- phosphoramide Triethylperazine Trifluoperazine Triflupromazine Trifluridine ophthalmic soln Triiodothyronine (T3) Trimethoprim/sulfadiazine Tripelennamine Trypan blue Tylosin Urea Urofollitropin